[Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
D000818:Animals; D001892:Camphanes / Q000494:pharmacology; D003864:Depression, Chemical; D005934:Glucagon / Q000378:metabolism*; D007003:Hypoglycemia / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D008297:Male; D010477:Perfusion; D051381:Rats; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000494:pharmacology*
D001892:Camphanes; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D005934:Glucagon
Der Einfluss eines neuen Sulfonylharnstoffes auf die Insulin-und Glukagonsekretion des isolierten perfundierten Pankreas.